Cited by 336Autism Spectrum Disorder ResearchGenetics and Neurodevelopmental DisordersGenomic variations and chromosomal abnormalities

Recurrent de novo mutations implicate novel genes underlying simplex autism risk

Open access
O'Roak, B. J., Stessman, H. A., Boyle, E. A., Witherspoon, K. T., Martin, B., Lee, C., Vives, L., Baker, C. +5 more·2014·Nature Communications

Abstract

Autism spectrum disorder (ASD) has a strong but complex genetic component. Here we report on the resequencing of 64 candidate neurodevelopmental disorder risk genes in 5,979 individuals: 3,486 probands and 2,493 unaffected siblings. We find a strong burden of de novo point mutations for these genes and specifically implicate nine genes. These include CHD2 and SYNGAP1, genes previously reported in related disorders, and novel genes TRIP12 and PAX5. We also show that mutation carriers generally have lower IQs and enrichment for seizures. These data begin to distinguish genetically distinct subtypes of autism important for aetiological classification and future therapeutics.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/ncomms6595

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Recent studies have reported additional individuals with ASD and/or NDD with de novo damaging variants in BRSK2, PAX5, NR4A2, RALGAPB, and DPP6.

    “Recent studies have reported additional individuals with ASD and/or NDD with de novo damaging variants in these genes including BRSK2,27 PAX5,4,28 NR4A2,29,30 RALGAPB,7,31,32 and DPP6.5,33,34”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
O'Roak, B. J., Stessman, H. A., Boyle, E. A., Witherspoon, K. T., Martin, B., Lee, C., Vives, L., Baker, C., Hiatt, J. B., Nickerson, D. A., Bernier, R., Shendure, J., & Eichler, E. E.
Affiliations
  • University of Washington (US)
  • Howard Hughes Medical Institute (US)
Corresponding author
  • Shendure, J.
  • Eichler, E. E.
Venue
Nature Communications
Published
2014-11-24
Volume
5
Issue
1
Pages
5595-5595
ISSN
2041-1723 (ISSN-L)
OpenAlex
W1979856142
Cited by
336
References
33
Citations by year
2026: 12 · 2025: 20 · 2024: 23 · 2023: 19 · 2022: 24 · 2021: 29 · 2020: 36 · 2019: 38 · 2018: 37 · 2017: 40 · 2016: 34 · 2015: 22
FWCI
17.70
Type
journal article
Language
en
Open access
Locations
  • Nature Communications (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
Funders
  • Howard Hughes Medical Institute
  • Simons Foundation
  • Simons Foundation Autism Research Initiative
  • National Institutes of Health
  • National Institute of Mental Health (R01MH101221)
  • National Institute of General Medical Sciences (T32GM007266)
Topics
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
Keywords
autism spectrum disorder, de novo mutations, CHD2, SYNGAP1, TRIP12, PAX5, intellectual disability, seizures, autism subtypes, genetic aetiology
MeSH terms
Autistic Disorder, Base Sequence, Carrier Proteins, DNA-Binding Proteins, Family, Humans, Intelligence, Intelligence Tests, Mutation, Risk, Sequence Analysis, DNA, Genetic Predisposition to Disease, ras GTPase-Activating Proteins, Ubiquitin-Protein Ligases, PAX5 Transcription Factor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review